University of California, Los Angeles (UCLA), Health Sciences

Grant boosts psychosocial care resources during COVID-19 pandemic

Newswise — LOS ANGELES — The Simms/Mann-UCLA Center for Integrative Oncology has received a $50,000 grant from Los Angeles-based PHASE ONE Foundation to support psychosocial care for people with cancer, their families and frontline healthcare workers during the COVID-19 pandemic.

The center is providing individual and group support for frontline COVID-19 staff in the hospitals by establishing virtual support groups and other empowering programs to help with the added burdens healthcare workers face during the pandemic.

In addition to supporting the UCLA Simms/Mann Center, the grant also inspired matching support from the community for UCLA Health’s COVID-19 Patient Care and Healthcare Provider Protection Fund.

 “PHASE ONE has supported cancer research for the past two decades, emphasizing funding innovative clinical trials. However, we also realize the importance of providing distinct resources through community grants,” said Edward A. Woods, PHASE ONE Board Member.

“The devastating reality of COVID-19 magnified the importance of supporting hospital programs, and we are thrilled to provide this grant to the Simms/Mann-UCLA Center for Integrative Oncology, particularly during this time of extreme psychological stressors. Our grant will not only provide support for patients and their families, but also for those who have shown unbelievable professional commitment as well as for those who continue to selflessly volunteer to assist those in need.”

 "The PHASE ONE grant greatly enhances the work of the center and extends its care to all those who have been touched by this pandemic – not just our patients with cancer and their loved ones, but also the frontline workers who are stepping in to provide emotional and spiritual support to those in greatest need,” said Kauser Ahmed, PhD, director of the Simms/Mann – UCLA Center for Integrative Oncology. “The grant allows the center to bring this vital and sustaining circle of care to all in our healthcare community.”

Psychosocial treatment at UCLA Simms/Mann Center, which is part of the UCLA Jonsson Comprehensive Cancer Center, UCLA Health and the Division of Hematology/Oncology in the David Geffen School of Medicine, involves a wide range of individual, family and group therapy in addition to psychiatric care. These services include educational programs in nutrition, spiritual care, qi gong and meditation; and workshops such as healing through art and preparing for surgery. The center’s mission is to empower patients and families with support that enhances their overall well-being as they go through the many challenges of a cancer diagnosis.

PHASE ONE is a nonprofit dedicated to supporting ground-breaking Phase I and Phase II clinical cancer research, innovative education and treatment programs, and funding forward-thinking leaders in the scientific and medical community.  PHASE ONE has raised more than 20 million dollars and has supported over 30 ground-breaking cancer clinical trials and treatments over the past 20 years.

 




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.54699